Pathogenic role of effector cells and immunoglobulins in cationic bovine serum albumin-induced membranous nephropathy

Journal of Clinical Immunology

Volumn 32, Issue 1, 2012, Pages 138-149

  Wu, Chia Chao ^a,b   Lu, Kuo Cheng ^c   Lin, Yuh Feng ^a,d   Chen, Jin Shuen ^a   Huang, Ching Feng ^a   Chen, Chun Chi ^a   Lin, Shih Hua ^a   Chu, Pauling ^a   Sytwu, Huey Kang ^b  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cationic bovine serum albumin; Effector cells; Immunoglobulins; Membranous nephropathy; Murine model

Indexed keywords

BOVINE SERUM ALBUMIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMET ASSAY; COMPLEMENT SYSTEM; CONTROLLED STUDY; EFFECTOR CELL; FEMALE; HISTOPATHOLOGY; IMMUNE COMPLEX DEPOSITION; MEMBRANOUS GLOMERULONEPHRITIS; MOUSE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEINURIA; SCID MOUSE; SPLEEN CELL; ANIMAL; APOPTOSIS; B LYMPHOCYTE; BAGG ALBINO MOUSE; BLOOD; CATTLE; CHEMICALLY INDUCED DISORDER; COMPLEMENT ACTIVATION; GLOMERULUS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PATHOLOGY; T LYMPHOCYTE;

ANIMALS; APOPTOSIS; B-LYMPHOCYTES; CATTLE; COMPLEMENT ACTIVATION; GLOMERULONEPHRITIS, MEMBRANOUS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS; KIDNEY GLOMERULUS; MICE; MICE, INBRED BALB C; MICE, SCID; NF-KAPPA B; OXIDATIVE STRESS; SERUM ALBUMIN, BOVINE; T-LYMPHOCYTES;

EID: 84862262393     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-011-9614-7     Document Type: Article

References (36)

1. Cattran DC. Idiopathic membranous glomerulonephritis. Kidney Int. 2001;59:1983-94. (Pubitemid 32336818)
2. Glassock RJ. Diagnosis and natural course of membranous nephropathy. Semin Nephrol. 2003;23:324-32. (Pubitemid 37022035)
3. Cattran D. Management of membranous nephropathy: when and what for treatment. J Am Soc Nephrol. 2005;16:1188-94. (Pubitemid 41716503)
4. Cunningham PN, Quigg RJ. Contrasting roles of complement activation and its regulation in membranous nephropathy. J Am Soc Nephrol. 2005;16:1214-22. (Pubitemid 41716506)
5. Nangaku M, Shankland SJ, Couser WG. Cellular response to injury in membranous nephropathy. J Am Soc Nephrol. 2005;16:1195-204. (Pubitemid 41716504)
6. Tipping PG, Kitching AR. Glomerulonephritis, Th1 and Th2: what's new? Clin Exp Immunol. 2005;142:207-15. (Pubitemid 41565235)
7. Ring GH, Lakkis FG. T lymphocyte-derived cytokines in experimental glomerulonephritis: testing the Th1/Th2 hypothesis. Nephrol Dial Transplant. 1998;13:1101-3. (Pubitemid 28227175)
8. Schena FP. Cytokine network and resident renal cells in glomerular diseases. Nephrol Dial Transplant. 1999;14 Suppl 1:22-6. (Pubitemid 29041830)
9. Hirayama K, Ebihara I, Yamamoto S, Kai H, Muro K, Yamagata K, et al. Predominance of type-2 immune response in idiopathic membranous nephropathy. Cytoplasmic cytokine analysis. Nephron. 2002;91:255-61. (Pubitemid 34621692)
10. Kuroki A, Iyoda M, Shibata T, Sugisaki T. Th2 cytokines increase and stimulate B cells to produce IgG4 in idiopathic membranous nephropathy. Kidney Int. 2005;68:302-10. (Pubitemid 43181389)
11. Masutani K, Taniguchi M, Nakashima H, Yotsueda H, Kudoh Y, Tsuruya K, et al. Up-regulated interleukin-4 production by peripheral T-helper cells in idiopathic membranous nephropathy. Nephrol Dial Transplant. 2004;19:580-6. (Pubitemid 38263116)
12. Oliveira DB. Membranous nephropathy: an IgG4-mediated disease. Lancet. 1998;351:670-1. (Pubitemid 28098462)
13. Penny MJ, Boyd RA, Hall BM. Role of T cells in the mediation of Heymann nephritis. II. Identification of Th1 and cytotoxic cells in glomeruli. Kidney Int. 1997;51:1059-68. (Pubitemid 27186531)
14. Bosma MJ, Carroll AM. The SCID mouse mutant: definition, characterization, and potential uses. Annu Rev Immunol. 1991;9:323-50.
15. Chen JS, Chen A, Chang LC, Chang WS, Lee HS, Lin SH, et al. Mouse model of membranous nephropathy induced by cationic bovine serum albumin: antigen dose-response relations and strain differences. Nephrol Dial Transplant. 2004;19:2721-8. (Pubitemid 39480964)
16. Wu CC, Chen JS, Lin SH, Chen A, Sytwu HK, Lin YF. Experimental model of membranous nephropathy in mice: sequence of histological and biochemical events. Lab Anim. 2008;42:350-9. (Pubitemid 352029864)
17. Wu CC, Chen JS, Chen SJ, Lin SH, Chen A, Chang LC, et al. Kinetics of adaptive immunity to cationic bovine serum albumin-induced membranous nephropathy. Kidney Int. 2007;72:831-40. (Pubitemid 47462076)
18. Wu CC, Lu KC, Chen JS, Hsieh HY, Lin SH, Chu P, et al. HO-1 induction ameliorates experimental murine membranous nephropathy: anti-oxidative, anti-apoptotic and immunomodulatory effects. Nephrol Dial Transplant. 2008;23:3082-90.
19. Penny MJ, Boyd RA, Hall BM. Permanent CD8(+) T cell depletion prevents proteinuria in active Heymann nephritis. J Exp Med. 1998;188:1775-84. (Pubitemid 28536765)
20. Spicer ST, Ha H, Boyd RA, He XY, Carter N, Tran G, et al. Il-4 therapy prevents the development of proteinuria in active Heymann nephritis by inhibition of Tc1 cells. J Immunol. 2001;167:3725-33. (Pubitemid 32910817)
21. Fervenza FC, Abraham RS, Erickson SB, Irazabal MV, Eirin A, Specks U, et al. Rituximab therapy in idiopathic membranous nephropathy: a 2-year study. Clin J Am Soc Nephrol. 2010;5:2188-98.
22. Remuzzi G, Chiurchiu C, Abbate M, Brusegan V, Bontempelli M, Ruggenenti P. Rituximab for idiopathic membranous nephropathy. Lancet. 2002;360:923-4. (Pubitemid 35283838)
23. Ruggenenti P, Chiurchiu C, Abbate M, Perna A, Cravedi P, Bontempelli M, et al. Rituximab for idiopathic membranous nephropathy: who can benefit? Clin J Am Soc Nephrol. 2006;1:738-48.
24. Kerjaschki D, Farquhar MG. The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border. Proc Natl Acad Sci U S A. 1982;79:5557-61. (Pubitemid 13197683)
25. Debiec H, Guigonis V, Mougenot B, Decobert F, Haymann JP, Bensman A, et al. Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med. 2002;346:2053-60. (Pubitemid 34680597)
26. Beck Jr LH, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361:11-21.
27. Debiec H, Lefeu F, Kemper MJ, Niaudet P, Deschenes G, Remuzzi G, et al. Early-childhood membranous nephropathy due to cationic bovine serum albumin. N Engl J Med. 2011;364:2101-10.
28. Fogo AB. Milk and membranous nephropathy. N Engl J Med. 2011;364:2158-9.
29. Ireland R. Glomerular disease: bovine serum albumin: involved in childhood membranous nephropathy? Nat Rev Nephrol. 2011;7:423.
30. Dean EG, Wilson GR, Li M, Edgtton KL, O'Sullivan KM, Hudson BG, et al. Experimental autoimmune Goodpasture's disease: a pathogenetic role for both effector cells and antibody in injury. Kidney Int. 2005;67:566-75. (Pubitemid 40139848)
31. Vlahakos DV, Foster MH, Adams S, Katz M, Ucci AA, Barrett KJ, et al. Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites. Kidney Int. 1992;41:1690-700.
32. Heymann F, Meyer-Schwesinger C, Hamilton-Williams EE, Hammerich L, Panzer U, Kaden S, et al. Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury. J Clin Invest. 2009;119:1286-97.
33. Suzuki H, Suzuki Y, Aizawa M, Yamanaka T, Kihara M, Pang H, et al. Th1 polarization in murine IgA nephropathy directed by bone marrow-derived cells. Kidney Int. 2007;72:319-27. (Pubitemid 47172373)
34. Chao TK, Rifai A, Ka SM, Yang SM, Shui HA, Lin YF, et al. The endogenous immune response modulates the course of IgAimmune complex mediated nephropathy. Kidney Int. 2006;70:283-97. (Pubitemid 44086578)
35. Kerjaschki D. Pathomechanisms and molecular basis of membranous glomerulopathy. Lancet. 2004;364:1194-6. (Pubitemid 39311326)
36. Ronco P, Debiec H. Molecular pathomechanisms of membranous nephropathy: from Heymann nephritis to alloimmunization. J Am Soc Nephrol. 2005;16:1205-13. (Pubitemid 41716505)